Twist Bioscience Corp Operating Income Loss

• Twist Bioscience Corp showed an increase of +38.3% in Operating Income Loss from 2024 to 2025.
• This data is from Twist Bioscience Corp's annual report (Form 10-K), filed with the SEC on November 17, 2025.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Twist Bioscience Corp's Operating Income Loss has declined by 133.0%.
• Historical annual values: Fiscal year 2025: -$136.26 million | Fiscal year 2024: -$220.83 million | Fiscal year 2023: -$217.16 million | Fiscal year 2022: -$234.78 million | Fiscal year 2021: -$152.73 million | Fiscal year 2020: -$140.08 million | Fiscal year 2019: -$108.85 million | Fiscal year 2018: -$70.56 million | Fiscal year 2017: -$58.48 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026